A trial looking at HA-Irinotecan for bowel cancer that has spread

Please note - this trial is no longer recruiting patients. We hope to add results when they are available.

Cancer type:

Bowel (colorectal) cancer
Colon cancer
Rectal cancer




Phase 3

This trial is comparing HA-Irinotecan with standard irinotecan, given alongside fluorouracil and folinic acid for bowel cancer that has spread.

If bowel cancer has spread to another part of the body, doctors can treat it with chemotherapy. They may use the drugs irinotecan, fluorouracil (also known as 5FU) and a vitamin called folinic acid. This combination of drugs is known as FOLFIRI chemotherapy.

Researchers are looking for ways to improve treatment. In this trial, they are testing a drug called HA-Irinotecan. It combines irinotecan with a substance called hyaluronic acid (HA). HA is a substance found naturally in the body but can also be made in the laboratory. We know from earlier research that HA can help to get more irinotecan into cancer cells. Doctors hope combining HA with irinotecan will kill more cancer cells than the form of irinotecan that is currently used.

In this trial, everybody will have fluorouracil and folinic acid. Half the people will also have irinotecan the other half will have HA-Irinotecan. The aims of the trial are to

  • See if HA-Irinotecan works better than irinotecan for bowel cancer that has spread
  • Learn more about the side effects

Who can enter

You can enter this trial if you

  • Have bowel cancer that has spread to another part of your body and has got worse despite having 1 or 2 other types of chemotherapy
  • Have at least 1 area of cancer that can be measured on a scan
  • Are well enough to carry out all your normal activities, apart from heavy physical work (performance status of 0 or 1)
  • Have satisfactory blood test results
  • Are willing to use a reliable form of contraception during the trial and for 4 weeks afterwards if there is any chance you or your partner could become pregnant
  • Are at least 18 years old

You cannot enter this trial if you

  • Have cancer that has spread to your brain or spinal cord (central nervous system) and has not been treated or is causing symptoms
  • Have already had irinotecan
  • Have had more than 2 other types of chemotherapy for bowel cancer that has spread – treatment after surgery to prevent cancer coming back (adjuvant treatment) is included in these 2 if your cancer came back within 6 months of finishing this treatment
  • Have had chemotherapy or surgery in the last 4 weeks, or have not recovered from any side effects of earlier treatment
  • Have had radiotherapy to your tummy (abdomen Open a glossary item) or to the area between your hip bones (pelvis Open a glossary item) in the last year
  • Have had an experimental drug as part of another clinical trial in the last month
  • Have had another cancer, apart from carcinoma in situ of the cervix, non melanoma skin cancer  or any other cancer that was successfully treated at least 5 years ago
  • Cannot have irinotecan - for example if you have inflammatory bowel disease, long term problems with diarrhoea, or a condition called Gilbert’s syndrome
  • Have a build up of fluid around your lungs (pleural effusion Open a glossary item) or in your tummy (ascites Open a glossary item) and it needs treatment
  • Have a blockage in your bowel (partial or complete bowel obstruction)
  • Have had a heart attack in the last 3 months or have other heart problems that are a cause for concern
  • Have an infection
  • Are pregnant or breastfeeding

Trial design

This international phase 3 trial will recruit about 390 people. It is a randomised trial. The people taking part are put into treatment groups by a computer.  Neither you nor your doctor will be able to decide which group you are in. And you will not know which group you are in either. This is called a double blind trial.

People in 1 group have irinotecan, fluorouracil and folinic acid. People in the other group have HA-Irinotecan, fluorouracil and folinic acid. You have all the drugs through a drip into a vein every 2 weeks. Each 2 week period is called a cycle of treatment.

On the first day of each treatment cycle, you have folinic acid and either irinotecan or HA-Irinotecan. This takes about an hour and a half. Then you have fluorouracil over the next 48 hours.

As long as your cancer does not get worse, you carry on having this treatment for up to 8 months.  If your doctor thinks the treatment is still helping, you may be able to carry on having it for longer.

The trial team will ask your permission to keep a sample of tissue taken when you had surgery. If you don’t want to give this sample for research, you don’t have to. You can still take part in the trial.

Hospital visits

You will see the doctors and have some tests before you start treatment. The tests include

You go to hospital every 2 weeks during treatment. Each time you have treatment it takes 2 days (48 hours). You may need to stay in hospital for 2 days, or you may be able to go home with a portable pump. You see the doctors, and have a physical examination and blood tests before each cycle of chemotherapy. And you have a CT or MRI scan every 6 weeks.

When you finish treatment, you go back to see the trial doctors 2 weeks later. Then you will see them every 6 weeks until your cancer starts to get worse. After that, they will contact you by phone every 3 months to see how you are.

Side effects

AS HA-Irinotecan is a new drug, there may be side effects that we don’t know about yet. But in an earlier trial, the side effects were similar to those of irinotecan. These included diarrhoea and a drop in blood cells causing an increased risk of infection, bleeding problems, tiredness and breathlessness.

There is more information about the possible side effects of FOLFIRI on CancerHelp UK.

Recruitment start:

Recruitment end:

How to join a clinical trial

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Chief Investigator

Dr Ian Chau

Supported by

Experimental Cancer Medicine Centre (ECMC)
National Institute for Health Research Cancer Research Network (NCRN)

Freephone 0808 800 4040

Last review date

CRUK internal database number:

Oracle 7914

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Wendy took part in a new trial studying the possible side effect of hearing loss

A picture of Wendy

"I was delighted to take part in a clinical trial as it has the potential to really help others in the future.”

Last reviewed:

Rate this page:

No votes yet
Thank you!
We've recently made some changes to the site, tell us what you think